BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38229155)

  • 21. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
    Zhang J; Liu J; Ding R; Miao X; Deng J; Zhao X; Wu T; Cheng X
    Aging (Albany NY); 2024 Mar; 16(6):5249-5263. PubMed ID: 38460960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
    Yang L; Liu J; Liu S
    BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.
    Zheng D; Wei Z; Guo W
    Front Genet; 2022; 13():849789. PubMed ID: 35518353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
    Wang H; Li J; Li X
    Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.
    Yang S; Liu L; Liu X; Li X; Zheng Y; Ren Z; Wang R; Wang Y; Li Q
    Medicine (Baltimore); 2023 Nov; 102(46):e36046. PubMed ID: 37986397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
    Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
    Liao Y; Liu Q; Xiao C; Zhou J
    J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 30. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer.
    Li F; Ma J; Yan C; Qi Y
    Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
    Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
    BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unfolded Protein Response-Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma.
    Zhang Z; Liu X; Cheng D; Dang J; Mi Z; Shi Y; Wang L; Fan H
    Front Genet; 2022; 13():911346. PubMed ID: 35754801
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of a Combined Oxidative Stress and Endoplasmic Reticulum Stress-Related Prognostic Signature for Hepatocellular Carcinoma.
    Ma H; Li Z; Chen R; Ren Z
    Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37957902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
    Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
    Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients.
    Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z
    Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.